Meds & supplements › Ciltacabtagene autoleucel
Medicine
Ciltacabtagene autoleucel
CARVYKTI is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least 1 prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Drug facts
- Used for
- CARVYKTI is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least 1 prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent
What it is used for
CARVYKTI is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least 1 prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent, and are refractory to lenalidomide.
Who should not take it
None.
Other medicines and interactions
HIV and the lentivirus used to make CARVYKTI have limited, short spans of identical genetic material (RNA). Therefore, some commercial HIV nucleic acid tests (NATs) may yield false-positive results in patients who have received CARVYKTI.
Storing it
Store and transport below -120 °C, e.g., in a container for cryogenic storage in the vapor phase of liquid nitrogen.
Store CARVYKTI in the original packaging containing the cassette protecting the infusion bag.
Thaw CARVYKTI prior to infusion.
Cite this page
- NLM
sofidex [Internet]. Daloreum; c2026. Ciltacabtagene autoleucel; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/ciltacabtagene-autoleucel
- APA 7th
sofidex. (2026, August 2). Ciltacabtagene autoleucel. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/ciltacabtagene-autoleucel
- AMA 11th
Ciltacabtagene autoleucel. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/ciltacabtagene-autoleucel
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.